Replies to post #83342 on Biotech Values

[DewDiligence]

I have heard David Bupp, Neoprobe CEO, make that projection [of $2B in sales] many times.

Am I supposed to be impressed that the company’s CEO is a bull artist?

[drbio45]

David Bupp also said five years ago that he would be able to file Riggs without a phase 3 based on data that he already had.

He also said that he could get Lymphoseek approved based on one successful phase 3 trial but the stock went up when he announced that he would do a second phase 3 trial.

Dutton received their info from David Bupp the former CFO.